Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/1999

01-04-1999

Association of angiogenesis and poor prognosis in node‐positive patients receiving anthracycline‐based adjuvant chemotherapy

Authors: P. Viens, J. Jacquemier, V.J. Bardou, F. Bertucci, F. Penault‐Llorca, B. Puig, G. Gravis, S. Oziel‐Taïeb, M. Resbeut, G. Houvenaeghel, J.ens Camerlo, D. Birbaum, J. Hassoun, D. Maraninchi

Published in: Breast Cancer Research and Treatment | Issue 3/1999

Login to get access
Metadata
Title
Association of angiogenesis and poor prognosis in node‐positive patients receiving anthracycline‐based adjuvant chemotherapy
Authors
P. Viens
J. Jacquemier
V.J. Bardou
F. Bertucci
F. Penault‐Llorca
B. Puig
G. Gravis
S. Oziel‐Taïeb
M. Resbeut
G. Houvenaeghel
J.ens Camerlo
D. Birbaum
J. Hassoun
D. Maraninchi
Publication date
01-04-1999
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 3/1999
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1006112927565

Other articles of this Issue 3/1999

Breast Cancer Research and Treatment 3/1999 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine